Cargando…
Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing
Autores principales: | Sachet, Monika, Lametschwandtner, Guenther, Hayden, Hubert, Hassler, Michaela, Loibner, Hans, Triozzi, Pierre, Friedl, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645272/ http://dx.doi.org/10.1186/2051-1426-3-S2-P172 |
Ejemplares similares
-
Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy
por: Lametschwandtner, Guenther, et al.
Publicado: (2014) -
Cbl-b silenced human NK cells respond stronger to cytokine stimulation
por: Lametschwandtner, Guenther, et al.
Publicado: (2015) -
Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors
por: Triozzi, Pierre, et al.
Publicado: (2015) -
Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model
por: Hinterleitner, Reinhard, et al.
Publicado: (2012) -
Overcoming immune-cell unresponsiveness in cancer
por: Lametschwandtner, Guenther, et al.
Publicado: (2013)